Epi Soul logo image Epi Soul logo image
  1. UW Home |
  2. SPH  |
  3. Other Departments |
Loading
online giving









































Christopher I. Li, MD, PhD, MPH


Research Professor, Epidemiology

Full Member,
Fred Hutchinson Cancer Research Center


Contact Information
Fred Hutchinson Cancer Research Center
Box 358080
1100 Fairview Ave N., M4-C308
P.O. 19024
Seattle, WA 98109-1024
Tel: 206-667-7444
Fax: 206-667-5948
http://www.fhcrc.org/
cili@fhcrc.org


Research Interests
My research interests lie principally in the field of breast cancer and understanding factors related to its etiology and outcomes using a multidisciplinary approach. I am actively investigating the relationships between various hormonal exposures and risks of different types of breast cancer based on their morphology and expression of different tumor markers. I am also interested in breast cancer outcomes and am currently leading studies that investigate risk factors for second primary breast cancer among breast cancer survivors. Another part of my work focuses on identifying markers that could be used for the early detection of different cancers using various proteomic platforms. Finally, I have an interest in examining disparities in cancer stage, treatment, and survival by race/ethnicity

Teaching Interests
Dr. Li currently co-teaches Epidemiology 524: Cancer Epidemiology during Winter Quarter.

Education
PhD, Epidemiology, University of Washington 2003
MD, Medicine, University of California (San Francisco) 2000
MPH, Epidemiology, University of Washington 2000
MD, Medicine, University of California (San Francisco) 2000
MPH, Epidemiology, University of Washington 2000

Projects
FHCRC
Information on projects



Selected Publications
Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Cushing-Haugen KL, Daling JR. The relationship between long-term use of hormone replacement therapy and risk of breast cancer among women 65-79 years of age. JAMA 2003;289:3254-3263.

Li CI, Daling JR, Porter PL, Tang MC, Malone KE. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor positive invasive breast cancer. J Clin Oncol 2009;27:5312-18.

Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O'Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the Women's Health Initiative Observational Study. J Natl Cancer Inst, 2010;102:1422-1431.

Pitteri SJ, Amon LM, Buson TB, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong C-H, Zhang Q, Wang H, Lampe PD, Prentice RL, McIntosh MW, Hanash SM, Li CI. Elevated plasma levels of epidermal growth factor receptor prior to the diagnosis of breast cancer. Cancer Research 2010;70:8598-606

Phipps AI, Chlebowski RT, Prentice R,McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI. Reproductive history and oral contraceptive use in relations to risk of triple-negative breast cancer. J Natl Cancer Inst 2011;103:1-8

Links
SciVal Experts Page

In the news
Blood pressure medication linked to breast cancer risk (FHCRC)
Study finds a link between injectable contraceptive use and increased risk of breast cancer in young women (FHCRC)

Last Reviewed on 7/29/2011

FacBio XML parser code Epi